| __timestamp | Dr. Reddy's Laboratories Limited | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 56369000000 | 5758000 |
| Thursday, January 1, 2015 | 62786000000 | 8423000 |
| Friday, January 1, 2016 | 62427000000 | 11986000 |
| Sunday, January 1, 2017 | 62453000000 | 15215000 |
| Monday, January 1, 2018 | 65724000000 | 15356000 |
| Tuesday, January 1, 2019 | 70421000000 | 16660000 |
| Wednesday, January 1, 2020 | 80591000000 | 52459000 |
| Friday, January 1, 2021 | 86645000000 | 75061000 |
| Saturday, January 1, 2022 | 100551000000 | 87221000 |
| Sunday, January 1, 2023 | 42907000000 | 83779000 |
| Monday, January 1, 2024 | 115557000000 |
Data in motion
In the ever-evolving pharmaceutical industry, understanding cost structures is crucial for strategic planning. Dr. Reddy's Laboratories Limited and Supernus Pharmaceuticals, Inc. offer a fascinating case study in cost management over the past decade. From 2014 to 2023, Dr. Reddy's Laboratories consistently maintained a high cost of revenue, peaking in 2024 with a staggering 115% increase from its 2014 figures. In contrast, Supernus Pharmaceuticals, Inc. demonstrated a more modest growth trajectory, with its cost of revenue increasing by approximately 1,400% over the same period. Notably, 2023 saw a significant dip for Dr. Reddy's, with costs dropping by nearly 57% from the previous year, highlighting potential strategic shifts or market challenges. Meanwhile, Supernus continued its upward trend, albeit with some missing data for 2024, suggesting either a strategic pause or data reporting gaps. This comparative analysis underscores the dynamic nature of cost management in the pharmaceutical sector.
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Dr. Reddy's Laboratories Limited
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Supernus Pharmaceuticals, Inc.
Cost of Revenue Trends: Takeda Pharmaceutical Company Limited vs Dr. Reddy's Laboratories Limited
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and Supernus Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for Dr. Reddy's Laboratories Limited and Corcept Therapeutics Incorporated
Analyzing Cost of Revenue: Dr. Reddy's Laboratories Limited and Ionis Pharmaceuticals, Inc.
Cost Insights: Breaking Down Dr. Reddy's Laboratories Limited and Xenon Pharmaceuticals Inc.'s Expenses
Cost of Revenue Comparison: Dr. Reddy's Laboratories Limited vs Iovance Biotherapeutics, Inc.
Cost Insights: Breaking Down Walgreens Boots Alliance, Inc. and Supernus Pharmaceuticals, Inc.'s Expenses
Cost Insights: Breaking Down Pharming Group N.V. and Supernus Pharmaceuticals, Inc.'s Expenses
Corcept Therapeutics Incorporated vs Supernus Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Supernus Pharmaceuticals, Inc. vs Wave Life Sciences Ltd.